| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V123992 | 2,3,5,6-Tetrafluorophenyl propionate-PEG3-amino-tetraxetan | 2247041-83-2 | 2,3,5,6-Tetrafluorophenyl propionate-PEG3-amino-tetraxetan is a chelating agent and linker conjugate that can be used in the synthesis of radiopharmaceuticals. |
|
V124803 | 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-(5-Cl)-Exatecan | 2813269-48-4 | 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-(5-Cl)-Exatecan is a drug-linker conjugate used in antibody-drug conjugates (ADCs). |
|
V126232 | 4-Arm-PEG2000-Acrylamide | 1818880-26-0 | |
|
V126234 | 4-Arm-PEG2000-Benzaldehyde | ||
|
V126242 | 4-Arm-PEG2000-Isocyanate | 724786-32-7 | |
|
V126260 | 4-Arm-PEG5000-Benzaldehyde | ||
|
V127715 | 8-Arm-PEG20000-Methyl acrylate | 2451100-15-3 | |
|
V127716 | 8-Arm-PEG20000-Norbornene | ||
|
V127734 | 8-Arm-PEG40000-Methyl acrylate | 2451100-15-3 | |
|
V35242 | AcLysValCit-PABC-DMAE-SW-163D | 2411007-69-5 | AcLysValCit-PABC-DMAE-SW-163D is part of the active antibody coupling molecule (drug-linker conjugates for ADC), which is made up of natural dual intercalator SW-163D and linker AcLysValCitPABC-DMAE coupling. |
|
V88381 | Amino-PEG4-GGFG-Dxd | 2879227-88-8 | Amino-PEG4-GGFG-Dxd (Compound 13-7) is a drug-linker conjugate composed of Dxd and linker, which can be used for the synthesis of ADC. |
|
V131214 | CCW16-C2-Boc | CCW16-C2-Boc is a conjugate targeting RNF4, which is formed by coupling the target protein ligand CCW16 with the PROTAC linker. | |
|
V33342 | CL2A-SN-38 | 1279680-68-0 | CL2A-SN-38, an SN-38 (topoisomerase-I inhibitor) analogue, is a peptide-based drug linker used to synthesize antibody drug conjugates (ADC). |
|
V133029 | Cyclopamine-COO-2-ethoxy-1,3-benzodioxole-O-C-Triazole-C5-AC | Cyclopamine-COO-2-ethoxy-1,3-benzodioxole-OC-Triazole-C5-AC is a drug-linker conjugate in which cyclopamine is the drug moiety. | |
|
V53086 | DBCO-(PEG)3-VC-PAB-MMAE | 2754384-60-4 | DBCO-(PEG)3-VC-PAB-MMAE is an active molecular conjugate (drug-linker conjugate for ADC). |
|
V52443 | DBCO-PEG4-GGFG-Dxd | 2694856-51-2 | DBCO-PEG4-GGFG-Dxd is part of an antibody-active molecule conjugate, consisting of the DNA topoisomerase I inhibitor Dxd and the cleavable ADC (Antibody-drug conjugate) linker DBCO-PEG4-GGFG. |
|
V118572 | DBCO-tag peptide P1 | DBCO-tagged peptide P1 is a cysteine-containing peptide tag. | |
|
V133444 | Demethylation-desulfuration-α-Amanitin-OH-PAB-Ala-Val-CO-C2-mal | Demethylation-desulfuration-α-Amanitin-OH-PAB-Ala-Val-CO-C2-mal is a conjugate of an ADC drug toxin molecule and a linker, containing a degradable PEG linker and a toxin molecule M-4, which is a cyclic peptide derived from α-amycin. | |
|
V88388 | Deruxtecan analog 2 monoTFA | 2758874-59-6 | Deruxtecan analog 2 (monoTFA) is a homologue of Deruxtecan, which is a conjugate of ADC toxin DX-8951 derivative (Dxd) and ADC Linker. |
|
V54776 | DGN549-L | 1884276-68-9 | DGN549-L contains a cleavable ADC?linker and a DNA alkylating agent for antibody conjugation of lysine residues. |